DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,480,438 | +2.5% | 42,243 | -0.7% | 2.59% | +5.7% |
| Q2 2023 | $10,226,339 | -12.5% | 42,562 | -8.1% | 2.45% | -13.7% |
| Q1 2023 | $11,685,703 | -3.4% | 46,315 | +1.7% | 2.83% | -14.9% |
| Q4 2022 | $12,101,467 | +3.4% | 45,551 | +0.7% | 3.33% | -6.3% |
| Q3 2022 | $11,700,000 | +2.8% | 45,254 | +0.9% | 3.56% | +7.4% |
| Q2 2022 | $11,379,000 | -12.2% | 44,839 | +1.5% | 3.31% | -0.8% |
| Q1 2022 | $12,966,000 | -9.6% | 44,164 | +1.4% | 3.34% | -2.1% |
| Q4 2021 | $14,338,000 | +9.0% | 43,551 | +0.8% | 3.41% | -2.3% |
| Q3 2021 | $13,157,000 | +12.4% | 43,186 | -0.9% | 3.49% | +10.2% |
| Q2 2021 | $11,702,000 | +18.4% | 43,573 | -0.7% | 3.17% | +10.9% |
| Q1 2021 | $9,886,000 | +1.0% | 43,882 | -0.3% | 2.86% | -7.4% |
| Q4 2020 | $9,786,000 | +1.9% | 44,019 | -1.2% | 3.08% | -8.8% |
| Q3 2020 | $9,599,000 | +22.1% | 44,541 | +0.3% | 3.38% | +11.6% |
| Q2 2020 | $7,861,000 | +29.8% | 44,409 | +1.6% | 3.03% | +7.6% |
| Q1 2020 | $6,058,000 | -7.7% | 43,709 | +2.3% | 2.82% | +12.8% |
| Q4 2019 | $6,566,000 | +5.7% | 42,736 | -0.5% | 2.50% | -1.5% |
| Q3 2019 | $6,211,000 | +1.2% | 42,955 | +0.1% | 2.54% | -3.3% |
| Q2 2019 | $6,139,000 | +9.8% | 42,904 | +1.5% | 2.62% | +5.4% |
| Q1 2019 | $5,590,000 | +28.7% | 42,290 | +0.6% | 2.49% | +12.9% |
| Q4 2018 | $4,342,000 | -0.6% | 42,039 | +4.7% | 2.20% | +7.9% |
| Q3 2018 | $4,367,000 | +10.4% | 40,134 | +0.3% | 2.04% | +4.1% |
| Q2 2018 | $3,955,000 | +0.9% | 40,014 | +0.1% | 1.96% | -1.5% |
| Q1 2018 | $3,921,000 | +6.8% | 39,979 | +1.2% | 1.99% | +3.7% |
| Q4 2017 | $3,672,000 | +11.2% | 39,497 | +2.7% | 1.92% | +7.4% |
| Q3 2017 | $3,303,000 | +1.9% | 38,442 | +0.1% | 1.79% | -1.7% |
| Q2 2017 | $3,240,000 | -0.8% | 38,388 | +0.5% | 1.82% | -2.3% |
| Q1 2017 | $3,266,000 | +12.0% | 38,188 | +2.0% | 1.86% | +3.3% |
| Q4 2016 | $2,915,000 | 0.0% | 37,453 | +0.7% | 1.80% | -1.7% |
| Q3 2016 | $2,915,000 | -20.3% | 37,188 | +2.7% | 1.83% | -23.4% |
| Q2 2016 | $3,657,000 | +6.6% | 36,208 | +0.1% | 2.39% | +4.4% |
| Q1 2016 | $3,430,000 | +0.5% | 36,158 | -1.6% | 2.29% | -3.2% |
| Q4 2015 | $3,413,000 | +16.1% | 36,745 | +6.5% | 2.36% | +2.6% |
| Q3 2015 | $2,940,000 | +7.5% | 34,500 | +7.9% | 2.30% | +3.9% |
| Q2 2015 | $2,736,000 | +2.3% | 31,970 | +1.5% | 2.22% | +0.8% |
| Q1 2015 | $2,675,000 | +2.3% | 31,510 | +3.3% | 2.20% | -2.2% |
| Q4 2014 | $2,615,000 | +15.1% | 30,510 | +2.1% | 2.25% | +6.5% |
| Q3 2014 | $2,271,000 | -3.5% | 29,890 | +0.0% | 2.11% | -3.4% |
| Q2 2014 | $2,353,000 | +3.5% | 29,885 | -1.4% | 2.19% | +3.1% |
| Q1 2014 | $2,273,000 | -0.5% | 30,310 | +2.5% | 2.12% | -6.9% |
| Q4 2013 | $2,284,000 | – | 29,580 | – | 2.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |